Bill Text: NY S03124 | 2025-2026 | General Assembly | Introduced
Bill Title: Requires the testing of newborns for spinal muscular atrophy; requires the department of health to educate the public and distribute informational materials on spinal muscular atrophy.
Spectrum: Partisan Bill (Republican 1-0)
Status: (Introduced) 2025-01-23 - REFERRED TO HEALTH [S03124 Detail]
Download: New_York-2025-S03124-Introduced.html
STATE OF NEW YORK ________________________________________________________________________ 3124 2025-2026 Regular Sessions IN SENATE January 23, 2025 ___________ Introduced by Sen. ORTT -- read twice and ordered printed, and when printed to be committed to the Committee on Health AN ACT to amend the public health law, in relation to the testing of newborns for spinal muscular atrophy and public education thereon The People of the State of New York, represented in Senate and Assem- bly, do enact as follows: 1 Section 1. Subdivision 1 of section 2500-a of the public health law, 2 as amended by chapter 730 of the laws of 2021, paragraph (j) as amended 3 by chapter 70 of the laws of 2022 and paragraph (k) as added by chapter 4 553 of the laws of 2023, is amended to read as follows: 5 1. It shall be the duty of the administrative officer or other person 6 in charge of each institution caring for infants twenty-eight days or 7 less of age and the person required in pursuance of the provisions of 8 section forty-one hundred thirty of this chapter to register the birth 9 of a child, to cause to have administered to every such infant or child 10 in its or his care a test for diseases and conditions designated by the 11 commissioner under regulations of the commissioner, and for: 12 (a) Phenylketonuria[.]; 13 (b) Homozygous sickle cell disease[.]; 14 (c) Hypothyroidism[.]; 15 (d) Branched-chain ketonuria[.]; 16 (e) Galactosemia[.]; 17 (f) Homocystinuria[.]; 18 (g) Critical congenital heart defects through pulse oximetry screen- 19 ing[.]; 20 (h) With regard to any newborn infant who is identified as, or 21 suspected of, having a hearing impairment as a result of a screening 22 conducted pursuant to section twenty-five hundred-g of this title, a 23 urine polymerase chain reaction (PCR) test for cytomegalovirus, unless 24 the parent of the infant objects thereto; provided that if the commis- 25 sioner determines that another test for cytomegalovirus is diagnos- EXPLANATION--Matter in italics (underscored) is new; matter in brackets [] is old law to be omitted. LBD06991-01-5S. 3124 2 1 tically equivalent to or better than the urine polymerase chain reaction 2 test, the commissioner may, by regulation under this section, allow or 3 require the use of that other test[.]; 4 (i) Adrenoleukodystrophy[.]; 5 (j) Glucose-6-phosphate dehydrogenase deficiency using a quantitative 6 enzymatic test or other diagnostic test in cases where: the newborn 7 infant presents with hemolytic anemia, hemolytic jaundice, or early-on- 8 set increasing neonatal jaundice, that is, jaundice (bilirubin level 9 greater than fortieth percentile for age in hours) persisting beyond the 10 day of birth through the week after birth; the newborn infant has been 11 admitted to the hospital for jaundice following birth; or the biological 12 parent of the newborn infant indicates a family, racial, or ethnic risk 13 of glucose-6-phosphate dehydrogenase deficiency, including having 14 significant African, Asian, Mediterranean, or Middle Eastern ancestry[.] 15 ; 16 (k) Duchenne muscular dystrophy using a test validated by the Wads- 17 worth center for laboratories and research[.]; and 18 (l) spinal muscular atrophy. 19 § 2. The public health law is amended by adding a new section 2500-n 20 to read as follows: 21 § 2500-n. Spinal muscular atrophy public education. 1. The department 22 shall develop and publish informational materials for women who may 23 become pregnant, expectant parents and parents of infants regarding: 24 (a) the incidence of spinal muscular atrophy; 25 (b) the risks of spinal muscular atrophy; 26 (c) birth defects caused by spinal muscular atrophy; 27 (d) methods of diagnosing spinal muscular atrophy; and 28 (e) available methods of treating spinal muscular atrophy and 29 resources available for families of children born with spinal muscular 30 atrophy. 31 2. The department shall publish the information required pursuant to 32 subdivision one of this section on its internet website, and distribute 33 information regarding birth defects, treatment and resources to all 34 hospitals performing spinal muscular atrophy testing pursuant to section 35 twenty-five hundred-a of this title. 36 3. The department may promulgate rules to implement the purposes of 37 this section. 38 § 3. This act shall take effect immediately; except that section one 39 of this act shall take effect on the one hundred twentieth day after it 40 shall have become a law. Effective immediately, the addition, amendment 41 and/or repeal of any rule or regulation necessary for the implementation 42 of section one of this act on its effective date are authorized to be 43 made and completed on or before such effective date.
